Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
CPC Subgroup Additional Only
C12N 2770/20011

Coronaviridae

Full Title

ssRNA viruses positive-sense > Details > Coronaviridae

12 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

  • C12N 2770/20021 Viruses as such, e.g. new isolates, mutants or their genomic sequences
  • C12N 2770/20022 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
  • C12N 2770/20023 Virus like particles [VLP]
  • C12N 2770/20031 Uses of virus other than therapeutic or vaccine, e.g. disinfectant
  • C12N 2770/20032 Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
  • C12N 2770/20033 Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
  • C12N 2770/20034 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
  • C12N 2770/20071 Demonstrated in vivo effect
  • C12N 2770/20088 for redistribution

Top Applicants

Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT

  1. HARVARD UNIVERSITY US 8,321
  2. CHINESE ACADEMY OF SCIENCES 7,486
  3. UNIVERSITY OF CALIFORNIA US 7,320
  4. REGENERON PHARMACEUTICALS US 5,003
  5. INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
  6. UNIVERSITY OF PENNSYLVANIA US 4,213
  7. CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
  8. JIANGNAN UNIVERSITY 3,961
  9. ROCHE CH 3,792
  10. ILLUMINA US 3,692